The goal of the Mehta Laboratory is to elucidate the regulatory network of genes critical for glioma formation and their resistance to therapy. This will greatly augment our ability to identify a druggable factor that could be targeted for glioma…
Our laboratory’s efforts are aimed at characterizing human GPCs and their germinal niche, and at developing a new set of human GPC-specific transcriptional and metabolic markers that enable real-time tracking of GPCs and glioma stem cells in live human brain.
The Scheck Laboratory’s work consists mainly of translational research to develop novel adjuvant therapies for the treatment of brain tumors. We also use various molecular and molecular genetic techniques to investigate why current therapies sometimes fail.
The primary goal of the Sirianni Laboratory is to engineer multifunctional nanocarriers for targeted treatment and imaging of brain tumors, with a focus on developing technologies that have the potential for clinical translation.